Le Lézard
Classified in: Environment, Health
Subjects: AWD, RCY, CSR, ENP

DaVita Medical Group Facility Awarded LEED® Gold Status



EL SEGUNDO, Calif., Sept. 13, 2017 /PRNewswire/ -- DaVita Medical Group, a division of DaVita Inc. (NYSE: DVA) and a leading independent medical group in the United States, today announced that its California headquarters facility has been awarded the Leadership in Energy & Environmental Design (LEED®) Gold certification by the U.S. Green Building Council (USGBC).

USGBC scores buildings in seven categories including sustainable sites, water efficiency, energy and atmosphere, materials and resources, indoor environmental quality, innovation in design and regional priority credits. Referred to as the Casa PacifiCA, in El Segundo, California, DaVita Medical Group's building received a Gold certification.

"We believe that being good stewards of our environment and our community are pivotal in our mission to build the leading independent medical group in America," said Jim McPhail, vice president of real estate and center development at DaVita. "By supporting a healthy environment and committing to sustainability we have the opportunity to improve health care in our community."  

Some building highlights of the Casa PacifiCA include:

DaVita, a national leader in sustainability efforts, is dedicated to its organizational initiative to pursue at least LEED® Silver certification for all business offices as part of the organization's 2020 environmental goals. The Casa PacifiCA certification, follows that of DaVita's World Headquarters in Denver, Colorado last year.

Learn more about DaVita's commitment to environmental sustainability for the future here.

About DaVita Medical Group
DaVita Medical Group is a division of DaVita Inc., a Fortune 500® company, that operates and manages medical groups and affiliated physician networks in California, Colorado, Florida, Nevada, New Mexico, Pennsylvania and Washington. A leading independent medical group in America, DaVita Medical Group has over two decades of experience providing coordinated, outcomes-based medical care in a cost-effective manner. DaVita Medical Group's teammates, employed clinicians and affiliated clinicians provided care for approximately 1.7 million patients. For more information, please visit DaVitaMedicalGroup.com.

About DaVita Inc.
DaVita Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and DaVita Medical Group. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of June 30, 2017, DaVita Kidney Care operated or provided administrative services at 2,445 outpatient dialysis centers located in the United States serving approximately 194,600 patients. The company also operated 217 outpatient dialysis centers located in 11 countries outside the United States. DaVita Medical Group manages and operates medical groups and affiliated physician networks in California, Colorado, Florida, Nevada, New Mexico, Pennsylvania and Washington in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. DaVita Medical Group's teammates, employed clinicians and affiliated clinicians provided care for approximately 1.7 million patients. For more information, please visit DaVita.com/About.

Contact Information

Media:
Jessica Geurkink
(720) 925-3184
Jessica.Geurkink@davita.com         

DaVita Medical Group (PRNewsfoto/DaVita Medical Group)

 

SOURCE DaVita Medical Group


These press releases may also interest you

at 22:30
ENGLEWOOD, Colo., Oct. 18, 2017 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) ("Ampio") today announced that it has closed it's previously announced registered direct offering of 7,709,400 shares of common stock at a purchase...

at 20:01
DENVER, Oct. 18, 2017 /PRNewswire/ -- MassRoots, Inc. (OTCQB:MSRT), one of the leading technology platforms for the cannabis industry, will hold a shareholder conference call hosted by the management team and Isaac Dietrich to discuss the Company's...

at 19:48
SAN CARLOS, Calif., Oct. 18, 2017 /PRNewswire-USNewswire/ -- The Bonnie J. Addario Lung Cancer Foundation (ALCF) and the International Association for the Study of Lung Cancer (IASLC) today announced the winner of the $300,000 ALCF-IASLC Second Joint...

at 19:36
RYE BROOK, N.Y., Oct. 18, 2017 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) hails today's U.S. Food and Drug Administration (FDA) approval of a new, personalized cell therapy that supercharges the patient's immune system to find...

at 19:13
TAMPA, Fla., Oct. 18, 2017 /PRNewswire-USNewswire/ -- The Food and Drug Administration announced today the approval of Yescartatm (Axicabtagene ciloleucel), a revolutionary new immunotherapy for adult patients with diffuse large B cell lymphoma, a...

at 19:07
OTTAWA, Oct. 18, 2017 /CNW/ - Update This notice has been updated to include information about a food recall warning that has been issued as part of the ongoing outbreak investigation. The Public Health Agency of Canada advises consumers not to eat...




News published on 13 september 2017 at 06:35 and distributed by: